
![]() |
|||||||||||||
WJPR Citation
|
| All | Since 2020 | |
| Citation | 8502 | 4519 |
| h-index | 30 | 23 |
| i10-index | 227 | 96 |
A NARRATIVE REVIEW OF FORMULATION OF POLYMERIC NANOPARTICLES ENCAPSULATING EZETIMIBE
Tamizharasan S.*, Senthilkumar K., Kannabirran Vaikumdam and Rajalingam D.
. Abstract Polymeric nanoparticles (PNPs) are characterized as particulate scatterings or strong particles with size in the scope of 10-1000nm. There has been an extensive exploration interest in the space of medication conveyance involving particulate conveyance frameworks as transporters for little and enormous particles. Particulate frameworks like nanoparticles have been utilized as an actual way to deal with change and work on the pharmacokinetic and pharmacodynamics properties of different sorts of medication particles. Polymeric nanoparticles have been widely concentrated as particulate transporters in the drug and clinical fields, since they show guarantee as medication conveyance frameworks because of their controlled and supported discharge properties, subcellular size, biocompatibility with tissue and cells. A few strategies to plan polymeric nanoparticles have been created and these methods are grouped by whether the molecule development includes a polymerization response or nanoparticles structure straightforwardly from a macromolecule or preformed polymer. In this audit the various methods for planning of polymeric nanoparticles are depicted. Keywords: Polymeric nanoparticles (PNPs). [Full Text Article] [Download Certificate] |
